Prior to joining MTS Health Partners as Vice President in 2016, Dr. Sudarov was a Senior Associate within Major Pharma/Life Sciences team at Credit Suisse. Prior to that she worked on Global Biotech Equity Research team covering both Large Cap and Small/Mid Cap Biotech stocks at Credit Suisse. Dr. Sudarov spent 5 years as a NIH funded Post-Doctoral Fellow at Weill Cornell Medical College in NYC focusing on synaptic plasticity underlying neurocognitive diseases. She obtained PhD in Cellular and Developmental Biology with focus in Developmental Genetics from NYU, and graduated summa cum laude with B.Sc. degree from FAU.